Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial oxidative phosphorylation enzymes are a group of multi-subunit protein complexes embedded in the inner mitochondrial membrane that drive the final and most energy-generating step of cellular respiration, producing over 90% of the cell’s ATP. These enzymes constitute the mitochondrial electron transport chain, consisting primarily of Complexes I–IV (redox-driven electron transport) and ATP synthase (Complex V, responsible for ATP production). Electrons derived from NADH and FADH₂ flow through these complexes, ultimately reducing oxygen to water and creating a proton gradient across the membrane. The energy stored in this gradient is harnessed by ATP synthase to generate ATP from ADP and inorganic phosphate. Defects in these enzymes underlie multiple human diseases—especially those affecting energy-demanding tissues such as brain, muscle, and heart—and are a frequent cause of inherited metabolic syndromes (“mitochondrial diseases”). These enzymes are also the pharmacological targets of various drugs and toxins, and their dysfunction is implicated in aging, cancer metabolism, and neurodegeneration[1][2][3][4][5][6][7][8].
Inhibition of electron transfer within complexes (e.g., I, III, IV), impairing ATP production; Induction of oxidative stress via ROS generation; Alteration of mitochondrial membrane potential; Modulation of cellular apoptosis by regulating ATP/ADP and proton gradients.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial oxidative phosphorylation enzyme.